Cardiovascular disease is the leading cause of death worldwide, with this trend predicted to
continue for the foreseeable future. Common disorders are associated with the stenosis or …

Regeneration of tissues using cells, scaffolds and appropriate growth factors is a key
approach in the treatments of tissue or organ failure. Silk protein fibroin can be effectively …

Silks are appealing materials for numerous biomedical applications involving drug delivery,
tissue engineering, or implantable devices, because of their tunable mechanical properties …

Tissue engineering (TE) involves the combination of cells with scaffolding materials and
appropriate growth factors in order to regenerate or replace damaged and degenerated …

Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …

Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and
hold promise as a source of grafting material when donor grafts are unsuitable or …

From microscaled capillaries to millimeter‐sized vessels, human vasculature spans multiple
scales and cell types. The convergence of bioengineering, materials science, and stem cell …

An osteoarthritis pandemic has accelerated exploration of various biomaterials for cartilage
reconstruction with a special emphasis on silk fibroin from mulberry (Bombyx mori) and non …

Tissue engineering (TE) is a multidisciplinary field that aims at the in vitro engineering of
tissues and organs by integrating science and technology of cells, materials and …

The increased demands of small-diameter vascular grafts (SDVGs) globally has forced the
scientific society to explore alternative strategies utilizing the tissue engineering …